EMA Authorised: Adenuric (febuxostat) — Menarini International Operations Luxembourg S.A. (MIOL)

View source ↗

Summary

The EMA authorised Adenuric (febuxostat) for the treatment of gout; the marketing authorization holder is Menarini International Operations Luxembourg S.A. (MIO…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout

Drugs mentioned

• Adenuric (febuxostat)

Snippet

Status: Authorised. Therapeutic area: Gout. MAH: Menarini International Operations Luxembourg S.A. (MIOL). Decision date: 12/09/2024